Padmanabh P. Bhatt's most recent trade in Supernus Pharmaceuticals Inc was a trade of 34,114 Common Stock done at an average price of $50.2 . Disclosure was reported to the exchange on March 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 50.18 per share. | 16 Mar 2026 | 34,114 | 32,930 (0%) | 0% | 50.2 | 1,711,841 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 49.95 per share. | 16 Mar 2026 | 27,710 | 39,334 (0%) | 0% | 50.0 | 1,384,115 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.40 per share. | 16 Mar 2026 | 22,750 | 39,794 (0%) | 0% | 39.4 | 896,350 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 16 Mar 2026 | 22,750 | 39,794 (0%) | 0% | 36.8 | 836,063 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2026 | 22,750 | 7,250 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2026 | 22,750 | 12,250 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 50.73 per share. | 16 Mar 2026 | 22,290 | 17,044 (0%) | 0% | 50.7 | 1,130,772 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.20 per share. | 16 Mar 2026 | 18,000 | 62,044 (0%) | 0% | 32.2 | 579,600 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2026 | 18,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 50.49 per share. | 16 Mar 2026 | 15,886 | 17,044 (0%) | 0% | 50.5 | 802,084 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.60 per share. | 16 Mar 2026 | 15,000 | 67,044 (0%) | 0% | 38.6 | 579,000 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2026 | 15,000 | 5,000 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2026 | 12,250 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 16 Mar 2026 | 12,250 | 52,044 (0%) | 0% | 36.8 | 450,188 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2026 | 7,250 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.40 per share. | 16 Mar 2026 | 7,250 | 24,294 (0%) | 0% | 39.4 | 285,650 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 49.55 per share. | 16 Mar 2026 | 6,838 | 17,456 (0%) | 0% | 49.6 | 338,823 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.94 per share. | 16 Mar 2026 | 5,000 | 67,044 (0%) | 0% | 27.9 | 139,700 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2026 | 5,000 | 15,000 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.61 per share. | 16 Mar 2026 | 4,250 | 44,044 (0%) | 0% | 29.6 | 125,843 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2026 | 4,250 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 50.48 per share. | 16 Mar 2026 | 412 | 17,044 (0%) | 0% | 50.5 | 20,798 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2026 | 1,250 | 17,694 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Feb 2026 | 1,250 | 1,250 | - | - | Restricted Stock Unit | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.69 per share. | 25 Feb 2026 | 650 | 17,044 (0%) | 0% | 50.7 | 32,949 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2026 | 1,250 | 17,090 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Feb 2026 | 1,250 | 2,500 | - | - | Restricted Stock Unit | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Feb 2026 | 1,125 | 3,375 | - | - | Restricted Stock Unit | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2026 | 1,125 | 16,025 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Feb 2026 | 750 | 0 | - | - | Restricted Stock Unit | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2026 | 750 | 16,194 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.86 per share. | 24 Feb 2026 | 646 | 16,444 (0%) | 0% | 50.9 | 32,856 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.35 per share. | 24 Feb 2026 | 581 | 15,444 (0%) | 0% | 51.3 | 29,834 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.86 per share. | 24 Feb 2026 | 354 | 15,840 (0%) | 0% | 50.9 | 18,004 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2026 | 13,500 | 13,500 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2026 | 3,000 | 3,000 | - | - | Restricted Stock Unit | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2025 | 1,500 | 15,218 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2025 | 1,500 | 0 | - | - | Performance Share Unit | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 44.44 per share. | 18 Dec 2025 | 710 | 14,508 (0%) | 0% | 44.4 | 31,552 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2025 | 1,500 | 1,500 | - | - | Performance Share Unit | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2025 | 1,250 | 0 | - | - | Performance Share Unit | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2025 | 1,250 | 14,299 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.46 per share. | 25 Aug 2025 | 581 | 13,718 (0%) | 0% | 41.5 | 24,088 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 1,250 | 1,250 | - | - | Performance Share Unit | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.05 per share. | 05 Mar 2025 | 575 | 12,704 (0%) | 0% | 33.1 | 19,004 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.05 per share. | 05 Mar 2025 | 575 | 13,279 (0%) | 0% | 33.1 | 19,004 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.05 per share. | 05 Mar 2025 | 335 | 13,854 (0%) | 0% | 33.1 | 11,072 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 1,650 | 0 | - | - | Performance Share Units | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 1,650 | 11,799 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Feb 2025 | 1,250 | 2,500 | - | - | Restricted Stock Unit | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Feb 2025 | 1,250 | 3,750 | - | - | Restricted Stock Unit | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 1,250 | 14,189 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 1,250 | 12,939 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.15 per share. | 21 Feb 2025 | 860 | 10,939 (0%) | 0% | 39.2 | 33,669 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 750 | 11,689 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Feb 2025 | 750 | 750 | - | - | Restricted Stock Unit | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 20,000 | 20,000 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 4,500 | 4,500 | - | - | Restricted Stock Unit | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 39.70 per share. | 04 Feb 2025 | 9,477 | 10,149 (0%) | 0% | 39.7 | 376,237 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.61 per share. | 04 Feb 2025 | 9,477 | 19,626 (0%) | 0% | 29.6 | 280,614 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2025 | 9,477 | 4,250 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2025 | 700 | 13,727 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 2,573 | 10,177 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.61 per share. | 27 Jan 2025 | 2,573 | 12,722 (0%) | 0% | 29.6 | 76,187 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 39.62 per share. | 27 Jan 2025 | 2,573 | 10,149 (0%) | 0% | 39.6 | 101,942 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 1,650 | 1,650 | - | - | Performance Share Units | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 39.62 per share. | 27 Jan 2025 | 700 | 10,149 (0%) | 0% | 39.6 | 27,734 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 700 | 9,477 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.61 per share. | 27 Jan 2025 | 700 | 10,849 (0%) | 0% | 29.6 | 20,727 | Common Stock |
| Supernus Pharma Inc | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 36.68 per share. | 03 Dec 2024 | 12,745 | 9,679 (0%) | 0% | 36.7 | 467,487 | Common Stock |
| Supernus Pharma Inc | Bhatt P. Padmanabh | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.30 per share. | 03 Dec 2024 | 12,745 | 22,424 (0%) | 0% | 25.3 | 322,449 | Common Stock |
| Supernus Pharma Inc | P. Padmanabh Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 12,745 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Bhatt P. Padmanabh | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 8,750 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh Bhatt P. | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.99 per share. | 03 Dec 2024 | 8,750 | 18,429 (0%) | 0% | 24.0 | 209,913 | Common Stock |
| Supernus Pharma Inc | P. Bhatt Padmanabh | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 36.68 per share. | 03 Dec 2024 | 8,750 | 9,679 (0%) | 0% | 36.7 | 320,950 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2024 | 1,250 | 0 | - | - | Performance Share Unit | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2024 | 1,250 | 10,251 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.57 per share. | 20 Aug 2024 | 572 | 9,679 (0%) | 0% | 29.6 | 16,914 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 1,250 | 1,250 | - | - | Performance Share Unit | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 35.31 per share. | 21 Mar 2024 | 14,491 | 8,570 (0%) | 0% | 35.3 | 511,677 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2024 | 14,491 | 12,745 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.30 per share. | 21 Mar 2024 | 14,491 | 23,061 (0%) | 0% | 25.3 | 366,622 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 400 | 27,236 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 35.31 per share. | 20 Mar 2024 | 400 | 8,570 (0%) | 0% | 35.3 | 14,124 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.30 per share. | 20 Mar 2024 | 400 | 8,970 (0%) | 0% | 25.3 | 10,120 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.30 per share. | 19 Mar 2024 | 12,364 | 20,934 (0%) | 0% | 25.3 | 312,809 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2024 | 12,364 | 27,636 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 35.31 per share. | 19 Mar 2024 | 12,364 | 8,570 (0%) | 0% | 35.3 | 436,573 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 36,116 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 33.48 per share. | 13 Mar 2024 | 36,116 | 8,570 (0%) | 0% | 33.5 | 1,209,164 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.98 per share. | 13 Mar 2024 | 36,116 | 44,686 (0%) | 0% | 13.0 | 468,786 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.99 per share. | 13 Mar 2024 | 26,250 | 34,820 (0%) | 0% | 24.0 | 629,738 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 26,250 | 8,750 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 34.10 per share. | 13 Mar 2024 | 26,250 | 8,570 (0%) | 0% | 34.1 | 895,125 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.98 per share. | 12 Mar 2024 | 3,884 | 12,454 (0%) | 0% | 13.0 | 50,414 | Common Stock |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2024 | 3,884 | 36,116 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 32.99 per share. | 12 Mar 2024 | 3,884 | 8,570 (0%) | 0% | 33.0 | 128,133 | Common Stock |
| Supernus Pharma Inc | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 5,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | P. Bhatt Padmanabh | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.13 per share. | 26 Feb 2024 | 5,000 | 13,570 (0%) | 0% | 9.1 | 45,650 | Common Stock |
| Supernus Pharma Inc | Padmanabh Bhatt P. | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 30.21 per share. | 26 Feb 2024 | 5,000 | 8,570 (0%) | 0% | 30.2 | 151,050 | Common Stock |
| Supernus Pharma Inc | Bhatt P. Padmanabh | Sr. VP of IP, CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Feb 2024 | 1,250 | 3,750 | - | - | Restricted Stock Unit |